Advertisement

Topics

Voce Comments on Natus’ Attempt to Present a Façade of Improved Governance

16:21 EDT 14 Jun 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Natus’ Midnight Conversion on Minimal Governance Items Must be Seen for What it is Proposed Board Changes Won’t Result in Annual Elections for All Directors Until 2022 Looming Presence of Chairman Gu...

Other Sources for this Article

Investors:
Okapi Partners LLC
Bruce H. Goldfarb / Patrick J. McHugh
212-297-0720
Toll-free 855-208-8902
info@okapipartners.com
or
Media:
Sloane & Company
Dan Zacchei / Joe Germani
212-486-9500
dzacchei@sloanepr.com / jgermani@sloanepr.com

NEXT ARTICLE

More From BioPortfolio on "Voce Comments on Natus’ Attempt to Present a Façade of Improved Governance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.